FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3126511322> ?p ?o ?g. }

• W3126511322 endingPage "138" @default.
• W3126511322 startingPage "135" @default.
• W3126511322 abstract "Abstract Catatonia is a well-established psycho-motor disorder occurring in the background of various psychiatric and medical disorders. Catatonia is commonly associated with psychiatric disorders, especially affective disorders followed by schizophrenia. However, almost 20% occur in the background of different medical and neurological disorders which need to be properly examined and investigated. Catatonia is a serious medical and psychiatric emergency condition; most probably caused by alteration in GABAergic circuits and basal ganglia. If untreated, catatonia can cause life threatening complications like dyselectrolemia, respiratory aspiration, venous thromboembolism, acute renal failure and cardiac arrest because of poor oral intake, immobility and muscular rigidity. The risk of mortality or serious life threatening events further increases in cases of children and adolescents. In children and adolescents, thus, it becomes even more important to diagnose catatonia early and start appropriate treatment. Lorazepam is considered to be the first line treatment and is safe both in adults and children. But evidence is scarce for treatment of lorazepam-resistant adolescent Catatonia. In this report we discuss two adolescent patients diagnosed with catatonia with no medical or neurological disorders in the background. Neither of the patients responded to lorazepam alone or even after augmentation with second generation antipsychotic (olanzapine). Zolpidem, like lorazepam, has a positive allosteric effect on GABA A Receptors (GABAAR) and has been used in some cases successfully to treat resistant catatonia. Here we used zolpidem 30 mg/day in divided doses with marked improvement in few days in all the symptoms. Both cases were discharged on zolpidem extended release (ER) three times a day and maintained well through the next two follow ups in over a two month period. Zolpidem can be a good alternative for children and adolescents in resistant cases." @default.
• W3126511322 created "2021-02-15" @default.
• W3126511322 creator A5063143298 @default.
• W3126511322 creator A5080395400 @default.
• W3126511322 date "2020-01-01" @default.
• W3126511322 modified "2023-09-25" @default.
• W3126511322 title "Zolpidem in treatment resistant adolescent catatonia: a case series" @default.
• W3126511322 cites W1532854697 @default.
• W3126511322 cites W1991351848 @default.
• W3126511322 cites W1997182472 @default.
• W3126511322 cites W2017424329 @default.
• W3126511322 cites W2037557590 @default.
• W3126511322 cites W2046770093 @default.
• W3126511322 cites W2062942122 @default.
• W3126511322 cites W2080088941 @default.
• W3126511322 cites W2106539321 @default.
• W3126511322 cites W2131826967 @default.
• W3126511322 cites W2137263182 @default.
• W3126511322 cites W2142050212 @default.
• W3126511322 cites W2165320263 @default.
• W3126511322 cites W2564535246 @default.
• W3126511322 cites W2611143478 @default.
• W3126511322 cites W2657034963 @default.
• W3126511322 cites W2733024172 @default.
• W3126511322 cites W2792958619 @default.
• W3126511322 cites W2955360820 @default.
• W3126511322 doi "https://doi.org/10.21307/sjcapp-2020-013" @default.
• W3126511322 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7863723" @default.
• W3126511322 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33564629" @default.
• W3126511322 hasPublicationYear "2020" @default.
• W3126511322 type Work @default.
• W3126511322 sameAs 3126511322 @default.
• W3126511322 citedByCount "4" @default.
• W3126511322 countsByYear W31265113222023 @default.
• W3126511322 crossrefType "journal-article" @default.
• W3126511322 hasAuthorship W3126511322A5063143298 @default.
• W3126511322 hasAuthorship W3126511322A5080395400 @default.
• W3126511322 hasBestOaLocation W31265113221 @default.
• W3126511322 hasConcept C118552586 @default.
• W3126511322 hasConcept C15744967 @default.
• W3126511322 hasConcept C2776412080 @default.
• W3126511322 hasConcept C2777123777 @default.
• W3126511322 hasConcept C2778941822 @default.
• W3126511322 hasConcept C2779706987 @default.
• W3126511322 hasConcept C2780494398 @default.
• W3126511322 hasConcept C2781210498 @default.
• W3126511322 hasConcept C42219234 @default.
• W3126511322 hasConcept C71924100 @default.
• W3126511322 hasConceptScore W3126511322C118552586 @default.
• W3126511322 hasConceptScore W3126511322C15744967 @default.
• W3126511322 hasConceptScore W3126511322C2776412080 @default.
• W3126511322 hasConceptScore W3126511322C2777123777 @default.
• W3126511322 hasConceptScore W3126511322C2778941822 @default.
• W3126511322 hasConceptScore W3126511322C2779706987 @default.
• W3126511322 hasConceptScore W3126511322C2780494398 @default.
• W3126511322 hasConceptScore W3126511322C2781210498 @default.
• W3126511322 hasConceptScore W3126511322C42219234 @default.
• W3126511322 hasConceptScore W3126511322C71924100 @default.
• W3126511322 hasIssue "1" @default.
• W3126511322 hasLocation W31265113221 @default.
• W3126511322 hasLocation W31265113222 @default.
• W3126511322 hasLocation W31265113223 @default.
• W3126511322 hasOpenAccess W3126511322 @default.
• W3126511322 hasPrimaryLocation W31265113221 @default.
• W3126511322 hasRelatedWork W1968479606 @default.
• W3126511322 hasRelatedWork W2131826967 @default.
• W3126511322 hasRelatedWork W2176814290 @default.
• W3126511322 hasRelatedWork W2474679401 @default.
• W3126511322 hasRelatedWork W3126511322 @default.
• W3126511322 hasRelatedWork W4353069340 @default.
• W3126511322 hasRelatedWork W5029964 @default.
• W3126511322 hasRelatedWork W2093207247 @default.
• W3126511322 hasRelatedWork W2225383675 @default.
• W3126511322 hasRelatedWork W2279405919 @default.
• W3126511322 hasVolume "8" @default.
• W3126511322 isParatext "false" @default.
• W3126511322 isRetracted "false" @default.
• W3126511322 magId "3126511322" @default.
• W3126511322 workType "article" @default.